Just the Facts: Top Published Papers

Top Published Papers

  • Cong, Q., Soteros, B. M., Wollet, M., Kim, J. H. & Sia, G. M. 2020, “The endogenous neuronal complement inhibitor SRPX2 protects against complement-mediated synapse elimination during development”, Nature Neuroscience 23, pp. 1067–1078.
  • Lawitz, E., Landis, C. S., Flamm, S. L., Bonacini, M., Ortiz-Lasanta, G., Huang, J., Zhang, J., Kirby, B. J., De-Oertel, S., Hyland, R. H., Osinusi, A. O., Brainard, D. M., Robson, R., Maliakkal, B. J., Gordon, S. C. & Gane, E. J. 2020, “Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicenter, phase 2b, non-randomized, open-label study,” The Lancet Gastroenterology & Hepatology vol 5, issue 10, pp. 918-926.
  • Qin, Y., Adams, J., Solis-Herrera, C., Triplitt, C., DeFronzo, R., Cersosimo, E. 2020, “Clinical parameters, fuel oxidation, and glucose kinetics in patients with type 2 diabetes treated with dapagliflozin plus saxagliptin”, Diabetes Care vol 43, issue 10, pp. 2519-2527.
  • Daw, C.C., Ramachandran, K., Enslow, B.T., Maity, S., Bursic, E., Novello, M.J., Rubannelsonkumar, C.S., Mashal, A.H., Ravichandran, J., Bakewell, T.M., Wang, W., Li, K., Madaris, T.R., Shannon, C.E., Norton, L., Kandala, S., Caplan, J., Srikantan, S., Stathopulos, P.B., Reeves, W.B., Muniswamy, M. 2020, “Lactate Elicits ER-Mitochondrial Mg2+ Dynamics to Integrate Cellular Metabolism”, Cell, vol 183, issue 2, pp. 474-489.
  • Ko, S. H., Apple, E. C., Liu, Z. & Chen, L. 2020, “Age-dependent autophagy induction after injury promotes axon regeneration by limiting NOTCH”, Autophagy, vol 16, issue 11, pp. 2052-2068.
  • Abdul-Ghani, M., Puckett, C., Adams, J., Khattab, A., Baskoy, G., Cersosimo, E., Triplitt, C. & DeFronzo, R. A. 2021, “Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-year follow-up of EDICT,” Diabetes Care, vol. 44, issue 2, pp. 433-439.
  • Jatoi, I. & Kemp, Z. 2021, “Risk-reducing mastectomy”, Journal of the American Medical Association, vol 325, issue 17, pp. 1781-1782.
  • Grivas, P. Khaki, A.R., Wise-Draper, T., French, B., Hennessy, C., Hsu, C-Y., Shyr, Y., Li, X., Choueiri, T.K., Painter, C.A., Peters, S., Rini, B.I., Thompson, M.A., Mishra, S., Rivera, D.R., Acoba, J.D., Abidi, M.Z., Bahouny, Z., Bashir, B., Bekaii-Saab, T., Berg, S., Bernicker, E.H., Bilen, M.A., Bindal, P., Bishnoi, R., Bouganim, N., Bowles, D.W., Cabal, A., Caimi, P.F., Chism, D.D., Crowell, J., Curran, C., Desai, A., Dixon, B., Doroshow, D.B., Durbin, E.B., Elkrief, A., Farmakiotis, D., Fazio, A., Fecher, L.A., Flora, D.B., Friese, C.R., Fu, J., Gadgeel, S.M., Galsky, M.D., Gill, D.M., Glover, M.J., Goyal, S., Grover, P., Gulati, S., Gupta, S., Halabi, S., Halfdanarson, T.R., Halmos, B., Hausrath, D.J., Hawley, D.J., Hsu, E., Huynh-Le, M., Hwang, C., Jani, C., Jayaraj, A., Johnson, D.B., Kasi, A., Khan, H., Koshkin, V.S., Kuderer, N.M., Kwon, D.H., Lammers, P.E., Li, A., Loaiza-Bonilla, A., Low, C.A., Lustberg, M.B., Lyman, G.H., McKay, R.R., McNair, C., Menon, H., Mesa, R.A., Mico, V., Mundt, D., Nagaraj, G., Nakazone, E.S., Nakayama, J., Nizam, A., Nock, N.L., Park, C., Patel, J.M., Patel, K.G., Peddi, P., Pennell, N.A., Piper-Vallillo, A.J., Puc, M., Ravindranathan, D., Reeves, M.E., Reuben, D.Y., Rosenstein, L., Rosovsky, R.P., Rubinstein, S.M., Salazar, M., Schmidt, A.L., Schwartz, G.K., Shah, M.R., Shah, S.A., Shah, C., Shaya, J.A., Singh, S.R.K., Smits, M., Stockerl-Goldstein, K.E., Stover, D.G., Streckfuss, M., Subbiah, S., Tachiki, L., Tadesse, E., Thakkar, A., Tucker, M.D., Verma, A.K., Vinh, D.C., Weiss, M., Wu, J.T., Wilff-Burchfield, W., Xie, Z., Yu, P.P., Zhang, T., Zhou, A.Y., Zhu, H., Zubiri, L., Shah, D.P., Warner, J.L., Lopes, GdL. 2020. “Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium,” Annals of Oncology, vol 32, issue 6, pp. 787-800.
  • Adams, S.G. & Peters, J.I. 2021, “In COPD, prophylactic macrolides, but not tetracyclines or quinolones, reduce exacerbations, with fewer serious adverse events”, Annals of Internal Medicine, vol 174, issue 6.
  • Seeker, P., & Osswald, S., 2021, “Tongue discoloration”, New England Journal of Medicine, vol 384.
  • Harrison, S. A., Bashir, M. R., Lee, K. J., Shim-Lopez, J., Lee, J., Wagner, B., Smith, N. D., Chen, H. C. & Lawitz, E. J. 2021, “A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis”, Journal of Hepatology, vol 75, issue 1, pp. 25-33.
  • Addeo, A., Shah, P. K., Bordry, N., Hudson, R. D., Albracht, B., Di Marco, M., Kaklamani, V., Dietrich, P. Y., Taylor, B. S., Simand, P. F., Patel, D., Wang, J., Labidi-Galy, I., Fertani, S., Leach, R. J., Sandoval, J., Mesa, R., Lathrop, K., Mach, N. & Shah, D. P. 2021, “Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer”, Cancer Cell, vol 39, issue 8, pp. 1091-1098.

Share this post!

In the 2021 issue of Future

Future is the official magazine of the Joe R. & Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio. Read and share inspiring stories highlighting our medical alumni, faculty and students who are revolutionizing education, research, patient care and critical services in the communities they serve.

View the 2021 issue

Categories for this article :